Injectables — safety by condition

Sources

1. EULAR (European Alliance of Associations for Rheumatology)EULAR recommendations for the management of rheumatoid arthritis (Smolen et al.)
2. PubMed Central (peer-reviewed meta-analysis)Methotrexate and infection risk in rheumatoid arthritis — meta-analysis (Ibrahim et al.)
3. The LancetBiologic treatment and serious infection risk in rheumatoid arthritis: systematic review and meta-analysis of 106 trials (Singh et al.)
4. British Association of DermatologistsGuidelines for the management of bullous pemphigoid
5. International Pemphigus and Pemphigoid FoundationLiving with pemphigus and pemphigoid
6. American Diabetes AssociationFoot care and diabetes
7. Diabetes UKLooking after your feet with diabetes
8. NHSDiabetes and foot problems
9. NICENG28 — Type 2 diabetes in adults: management
10. British Heart FoundationHeart Matters — patient information, massage and complementary therapy guidance
11. NHSIron deficiency anaemia
12. BMC Pregnancy and ChildbirthFatal pulmonary embolism following leg massage in undiagnosed deep vein thrombosis (case report)
13. British Association of DermatologistsTinea (dermatophyte infection) management
14. NHSRingworm and other fungal infections
15. NHSAthlete's foot
16. NICEClinical Knowledge Summary: fungal skin infection
17. Primary Care Dermatology SocietyFungal skin infections
18. British Association of DermatologistsBacterial skin infection management
19. NHSBoils and carbuncles
20. NHSMRSA
21. NHSCellulitis and erysipelas
22. NHSImpetigo
23. NICEClinical Knowledge Summary: impetigo
24. UKHSAUK Standards for Microbiology Investigations
25. NHSDiarrhoea and vomiting (gastroenteritis)
26. NHSFlu (influenza)
27. NHSCommon cold
28. NHSCOVID-19
29. UKHSALiving safely with respiratory infections, including COVID-19
30. NHSChickenpox
31. Royal College of Obstetricians and GynaecologistsChickenpox in pregnancy
32. UKHSAChickenpox (varicella): guidance
33. CDCUniversal precautions for prevention of transmission of bloodborne infections
34. NHSHIV and AIDS — how HIV is transmitted
35. National AIDS TrustHIV guidance for hairdressers and beauty professionals
36. StatPearls / NCBIUniversal precautions (Kopitnik & Kahwaji)
37. UK ParliamentEquality Act 2010, Schedule 1
38. British Association of DermatologistsHerpes zoster management
39. NHSShingles
40. UKHSAImmunisation against infectious disease (the Green Book), chapter 28a — Shingles (herpes zoster)
41. NHSTuberculosis (TB)
42. NICENG33 Tuberculosis
43. UKHSANotifiable diseases and causative organisms: how to report
44. UKHSATuberculosis: guidance, data and analysis
45. NHS Scotland (Scottish Dermatology Society)Viral warts pathway
46. NICEClinical Knowledge Summary: warts and verrucae
47. Primary Care Dermatology SocietyWarts and verrucae — patient information leaflet
48. MDPI (peer-reviewed)The Risk of Using Cosmetics and Cosmetic Procedures During Pregnancy
49. Pregnancy, Birth and Baby (Australian Government)Cosmetic procedures and beauty treatments during pregnancy and breastfeeding
50. American College of Obstetricians and GynecologistsSkin conditions during pregnancy
51. NHSPregnancy skincare guidance
52. US Food and Drug AdministrationPregnancy and Lactation Labeling (Drugs) Final Rule
53. Allergan (AbbVie)BOTOX (onabotulinumtoxinA) prescribing information
54. Age UKWellbeing, touch and personal care in later life
55. British Geriatrics SocietyFit for Frailty — recognising and managing frailty
56. NICENG56 — Multimorbidity: clinical assessment and management
57. American Journal of Medical Genetics Part CThe 2017 international classification of the Ehlers-Danlos syndromes (Malfait et al.)
58. Ehlers-Danlos Support UKLiving with EDS — skin, healing and bruising
59. NHSEhlers-Danlos syndromes
60. The Ehlers-Danlos SocietyEDS types, skin fragility and joint hypermobility
61. Hospice UKComplementary therapies and personal care in hospice settings
62. Look Good Feel Better UKNail care, skin care and makeup during cancer treatment
63. Macmillan Cancer SupportComplementary therapies and wellbeing
64. Marie CurieComfort, dignity and personal care at the end of life
65. NHSBody image and self-esteem
66. UK Obesity FederationDignity, equipment and access in service settings
67. British Association of Aesthetic Plastic SurgeonsPost-operative recovery timelines
68. NHSRecovering from an operation
69. Royal College of Surgeons of EnglandRecovering from surgery — patient information
70. JAMA DermatologyDelayed inflammatory reactions to hyaluronic acid fillers after COVID-19 vaccination — case reports
71. Equality and Human Rights CommissionReasonable adjustments for disabled people — guidance for service providers
72. MencapCommunicating with people with a learning disability
73. RNIBServing customers with sight loss
74. RNIDCommunication tips for serving deaf customers
75. ScopeMaking services accessible to disabled customers
76. UK Parliament (legislation.gov.uk)Disability Discrimination Act 1995 (as amended, Northern Ireland)
77. British Association of DermatologistsSkin cancer recognition guidance
78. NHSMoles and the ABCDE checks for melanoma
79. National Institute for Health and Care ExcellenceNG12 — Suspected cancer: recognition and referral
80. American Academy of DermatologyPost-procedure healing guidance
81. American Academy of DermatologyCosmetic procedure guidelines
82. British Association of DermatologistsHerpes simplex management guidance
83. NHSCold sores (herpes simplex) patient information
84. American Academy of DermatologyKeloid management guidelines
85. British Association of DermatologistsGuidance for skin of colour
86. British Association of DermatologistsPsoriasis guidelines
87. National Institute for Health and Care ExcellenceClinical Knowledge Summary — Psoriasis
88. National Psoriasis FoundationKoebner phenomenon and trigger management
89. General Medical Council (UK)Good Medical Practice
90. UK legislationMental Capacity Act 2005
91. Kidney Care UKLiving with kidney disease — patient information
92. NHSChronic kidney disease
93. NICEChronic kidney disease: assessment and management (NG203)
94. Alzheimer's SocietyDementia — information and support
95. Dementia UKPersonal care and wellbeing in dementia
96. NICEDementia: assessment, management and support (NG97)
97. British Association of DermatologistsPatch testing — patient information
98. British Contact Dermatitis SocietyContact allergy guidance
99. UK legislationThe Cosmetic Products Enforcement Regulations 2013
100. British Thyroid FoundationThyroid disorders — patient information
101. NHSUnderactive thyroid (hypothyroidism)
102. NICE Clinical Knowledge SummariesHypothyroidism
103. British Menopause SocietyMenopause — clinical guidance for patients
104. NHSMenopause and perimenopause
105. NICEMenopause: identification and management (NG23)
106. The Menopause CharityMenopause symptoms and skin changes
107. Allergan / MHRA Summary of Product CharacteristicsBotox (botulinum toxin type A) prescribing information — neuromuscular disorders
108. American Academy of NeurologyMyasthenia gravis management guidance
109. Myasthenia Gravis Association UKBotulinum toxin and myasthenia gravis
110. NICEMyasthenia gravis pathway
111. British Association of Aesthetic Plastic SurgeonsPosition statement on cosmetic procedures for under-18s
112. UK Parliament (legislation.gov.uk)Botulinum Toxin and Cosmetic Fillers (Children) Act 2021
113. British Association of DermatologistsHyperhidrosis guidelines
114. NHSCommissioning policy — botulinum toxin for severe hyperhidrosis
115. National Institute for Health and Care ExcellenceClinical Knowledge Summary — Hyperhidrosis
116. NICEHeadaches in over 12s: diagnosis and management (CG150)
117. National Migraine CentreBotulinum toxin for chronic migraine — patient information
118. The Migraine TrustMigraine triggers
119. American Academy of DermatologyAtopic dermatitis guidelines
120. National Eczema Society (UK)Trigger avoidance and treatment-flare guidance
121. National Institute for Health and Care ExcellenceClinical Knowledge Summary — Eczema (atopic) in adults